Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors(274 views visite) Di Fiore A, Maresca A, Supuran CT, De Simone G
Keywords Parole chiave: Aliphatic Compound, Aromatic Compound, Carbonate Dehydratase Inhibitor, Hydroxamic Acid, Sulfonamide, Zinc, Article, Catalysis, Chemical Structure, Enzyme Active Site, Enzyme Inhibition, Human, Metal Binding, Nonhuman, Carbonic Anhydrase Inhibitors, Catalytic Domain, Chelating Agents, Coordination Complexes, Crystallography, X-Ray, Isoenzymes, Models, Molecular, Protein Binding, Structure-Activity Relationship,
Affiliations Affiliazioni: *** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini - CNR, Napoli, Italy Università Degli Studi di Firenze, Sesto Fiorentino, Florence, Italy Universit Degli Studi di Firenze, Sesto Fiorentino, Florence, Italy
References Riferimenti: Supuran, C.T., (2008) Nat. Rev. Drug Discovery, 7, p. 16
Alterio, V., Di Fiore, A., D'Ambrosio, K., Supuran, C.T., De Simone, G., (2012) Chem. Rev., , 10.1021/cr200176r
Supuran, C.T., Winum, J.-Y., (2009) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications, , Wiley, Hoboken, New Jersey, Part II
Supuran, C.T., (2011) Future Med. Chem., 3, p. 1165
Pastorekova, S., Parkkila, S., Pastorek, J., Supuran, C.T., (2004) J. Enzyme Inhib. Med. Chem., 19, p. 199
Monti, S.M., Supuran, C.T., De Simone, G., (2012) Curr. Med. Chem., 19, p. 821
Supuran, C.T., Di Fiore, A., De Simone, G., (2008) Expert Opin. Emerging Drugs, 13, p. 383
Supuran, C.T., Scozzafava, A., Conway, J., (2004) Carbonic Anhydrase: Its Inhibitors and Activators, , CRC Press, Boca Raton, FL
Winum, J.-Y., Scozzafava, A., Montero, J.-L., Supuran, C.T., (2006) Med. Res. Rev., 26, p. 767
Di Fiore, A., Maresca, A., Alterio, V., Supuran, C.T., De Simone, G., (2011) Chem. Commun., 47, p. 11636
Fisher, J.F., Mobashery, S., (2006) Cancer Metastasis Rev., 25, p. 115
Ludwig, A., Hundhausen, C., Lambert, M.H., Broadway, N., Andrews, R.C., Bickett, D.M., Leesnitzer, M.A., Becherer, J.D., (2005) Comb. Chem. High Throughput Screening, 8, p. 161
El Yazal, J., Pang, Y.-P., (1999) J. Phys. Chem. A, 103, p. 8346
Bagno, A., Comuzzi, C., Scorrano, G., (1994) J. Am. Chem. Soc., 116, p. 916
Lindskog, S., Silverman, D.W., (2000) The Carbonic Anhydrase: New Horizons, pp. 175-195. , ed. W. R. Chegwidden, Y. H. Edwards and N. D. Carter, Birkhäuser Verlag, Basel, Switzerland
Rao, B.G., (2005) Curr. Pharm. Des., 11, p. 295
Supuran, C. T., (2008) Nat. Rev. Drug Discovery, 7, p. 16
Supuran, C. T., Winum, J. -Y., (2009) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications, , Wiley, Hoboken, New Jersey, Part II
Supuran, C. T., (2011) Future Med. Chem., 3, p. 1165
Monti, S. M., Supuran, C. T., De Simone, G., (2012) Curr. Med. Chem., 19, p. 821
Supuran, C. T., Di Fiore, A., De Simone, G., (2008) Expert Opin. Emerging Drugs, 13, p. 383
Supuran, C. T., Scozzafava, A., Conway, J., (2004) Carbonic Anhydrase: Its Inhibitors and Activators, , CRC Press, Boca Raton, FL
Winum, J. -Y., Scozzafava, A., Montero, J. -L., Supuran, C. T., (2006) Med. Res. Rev., 26, p. 767
Fisher, J. F., Mobashery, S., (2006) Cancer Metastasis Rev., 25, p. 115
Andrews, K. T., Tran, T. N., Wheatley, N. C., Fairlie, D. P., (2009) Curr. Top. Med. Chem., 9, p. 292
Marques, S. M., Nuti, E., Rossello, A., Supuran, C. T., Tuccinardi, T., Martinelli, A., Santos, M. A., (2008) J. Med. Chem., 51, p. 7968
Santos, M. A., Marques, S., Vullo, D., Innocenti, A., Scozzafava, A., Supuran, C. T., (2007) Bioorg. Med. Chem. Lett., 17, p. 1538
Scolnick, L. R., Clements, A. M., Liao, J., Crenshaw, L., Hellberg, M., May, J., Dean, T. R., Christianson, D. W., (1997) J. Am. Chem. Soc., 119, p. 850
Eriksson, A. E., Jones, T. A., Liljas, A., (1988) Proteins: Struct., Funct., Genet., 4, p. 274
Rao, B. G., (2005) Curr. Pharm. Des., 11, p. 295
Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(198 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(277 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(406 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(224 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(399 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote